Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
75
0.860
Why?
Bone Neoplasms
2
2023
184
0.780
Why?
Phenylthiohydantoin
1
2016
2
0.520
Why?
Warfarin
1
2016
84
0.480
Why?
Anticoagulants
1
2016
279
0.410
Why?
Thrombosis
1
2016
262
0.410
Why?
Ketoconazole
1
2010
10
0.350
Why?
Androgen Antagonists
1
2010
11
0.340
Why?
Carcinoma, Renal Cell
1
2011
111
0.330
Why?
Sulfonamides
1
2011
134
0.330
Why?
Proton Pump Inhibitors
1
2010
86
0.320
Why?
Pyrimidines
1
2011
200
0.320
Why?
Kidney Neoplasms
1
2011
181
0.310
Why?
Protein Kinase Inhibitors
1
2011
228
0.300
Why?
Antineoplastic Agents
1
2016
1221
0.280
Why?
Prostatic Neoplasms
1
2010
400
0.260
Why?
Drug Interactions
2
2016
205
0.200
Why?
Phthalazines
1
2022
20
0.190
Why?
Piperazines
1
2022
125
0.180
Why?
Indoles
1
2022
277
0.160
Why?
Prospective Studies
1
2023
2457
0.130
Why?
Retrospective Studies
3
2023
6671
0.130
Why?
Nitriles
1
2016
52
0.130
Why?
Benzamides
1
2016
50
0.130
Why?
Humans
6
2023
52593
0.120
Why?
Male
4
2022
26863
0.100
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
48
0.090
Why?
Indazoles
1
2011
47
0.090
Why?
Prostate-Specific Antigen
1
2010
44
0.080
Why?
Drug Resistance
1
2010
68
0.080
Why?
Treatment Outcome
2
2011
5486
0.080
Why?
Diphosphonates
1
2011
92
0.080
Why?
Imidazoles
1
2011
124
0.080
Why?
Middle Aged
3
2016
13096
0.080
Why?
Disease-Free Survival
1
2010
464
0.080
Why?
Gastrointestinal Diseases
1
2010
125
0.080
Why?
Drug Therapy, Combination
1
2010
400
0.080
Why?
Aged, 80 and over
2
2011
3420
0.060
Why?
Acute Kidney Injury
1
2011
392
0.060
Why?
Aged
2
2011
10191
0.040
Why?
Animals
1
2011
13507
0.030
Why?
Creatinine
1
2011
159
0.020
Why?
Incidence
1
2011
1077
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1378
0.020
Why?
Time Factors
1
2011
3000
0.010
Why?
Neoplasms
1
2011
1308
0.010
Why?
Adult
1
2011
14170
0.010
Why?
Female
1
2011
28262
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description